Prelude Capital Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $1.29M | Buy |
|
|||||
|
2024
Q3 | $415K | Sell |
|
|||||
|
2024
Q2 | $569K | Sell |
|
|||||
|
2024
Q1 | $491K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $255K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $271K | Sell |
|
|||||
|
2022
Q3 | $792K | Sell |
|
|||||
|
2022
Q2 | $643K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $523K | Buy |
|
|||||
|
2021
Q3 | $446K | Sell |
|
|||||
|
2021
Q2 | $860K | Buy |
|
|||||
|
2021
Q1 | $337K | Sell |
|
|||||
|
2020
Q4 | $879K | Buy |
|
|||||
|
2020
Q3 | $639K | Buy |
|
|||||
|
2020
Q2 | $296K | Buy |
|
|||||
|
2020
Q1 | $50K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1K | Sell |
|
|||||
|
2019
Q2 | $121K | Sell |
|
|||||
|
2019
Q1 | $268K | Sell |
|
|||||
|
2018
Q4 | $340K | Buy |
|